IRD
Opus Genetics, Inc.$4.35-0.23 (-5.02%)Prev Close$4.58·MCap$332.4M·P/E—·Vol618.5K·Yield—
▲
Buys (12M)
1
$323.7K
▼
Sells (12M)
6
$8.80M
◆
Net Activity
Net Seller
$8.47M
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at Opus Genetics, Inc. (IRD) has been dominated by selling, with 1 insider purchase totaling $323.7K and 6 insider sales totaling $8.80M. The most recent insider transaction was by Jayagopal Ashwath (officer: Chief Scientific & Dev. Ofc.), who sold $19.0K worth of shares on Mar 18, 2026. Opus Genetics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $332.4M.
IRD Insider Trading Activity
IRD Insider Buying Activity
The following table shows recent insider purchases of Opus Genetics, Inc. (IRD) stock reported via SEC Form 4 filings.
IRD Insider Selling Activity
The following table shows recent insider sales of Opus Genetics, Inc. (IRD) stock reported via SEC Form 4 filings.